Skip to main navigation Skip to search Skip to main content

Population pharmacokinetics and exposure–response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY

  • Mita Kuchimanchi
  • , Trine Lembrecht Jørgensen
  • , Eva Hanze
  • , Thierry André
  • , Angela Jain
  • , Dominique Berton
  • , Oskar Alskär
  • , Oleksandr Zub
  • , Ana Oaknin
  • , Mark S. Shahin
  • , Anthoula Koliadi
  • , Bhavana Pothuri
  • , Tom Krivak
  • , Mikalai Pishchyk
  • , Yakir Segev
  • , Floor J. Backes
  • , Christine Gennigens
  • , Sara Bouberhan
  • , Stefan Zajic
  • , Murad Melhem
  • Joseph Buscema

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Population pharmacokinetics and exposure–response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science